Chase AIPricingFAQs
Display currency
Loading news…

Haemato

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Schönefeld, Brandenburg, Germany Founded 1993 51-100 employees For Profit

Haemato is a pharmaceutical company that develops customized medical devices for the healthcare sector.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
1
Monthly Visits
Available in Pro
Contacts
0
Ticker
HAE
ETR - Deutsche Börse XETRA
Patents
0
1 trademarks

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Public
Ticker
HAE
Exchange
ETR - Deutsche Börse XETRA
IPO date
Sep 13, 2013

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
8
Patents granted
0
Trademarks
1
IT spend
$9M

Company Info

Founded
1993
Employees
51-100
Operating status
Active
Company type
For Profit
Org types
company
News articles
20
HQ
Schönefeld, Brandenburg, Germany
Region
European Union (EU), Europe, Middle East, and Africa (EMEA)
Exit date
Sep 13, 2013

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
0
Trend (30d)
-0.3
Trend (90d)
-0.3

Acquisitions by Haemato

Loading columns…
0 of 0Show
Page 1 / 1

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Haemato

Loading news…

FAQs about Haemato

People who checked this page also checked these

Sectors Haemato invests & acquires in

M&A by year

Browse the full Acquirezy directory.
Haemato - Company Profile, Full Acquisitions List, Funding and Investments